Novel activity of acriflavine against colorectal cancer tumor cells

Triterpenoid pristimerin synergizes with taxol to induce cervical cancer cell death through reactive oxygen species-mediated mitochondrial dysfunction

(2011) Da-Young Eum et al.   ANTI-CANCER DRUGS

Anti-cancer natural products isolated from chinese medicinal herbs

(2011) Wen Tan et al.   Chinese Medicine

A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin

(2009) Christopher Cao et al.   ANNALS OF SURGICAL ONCOLOGY

Characterization of the cytotoxic properties of the benzimidazole fungicides, benomyl and carbendazim, in human tumour cell lines and primary cultures of patient tumour cells

(2009) Daniel Laryea et al.   ANTI-CANCER DRUGS

Incremental Advance or Seismic Shift? The Need to Raise the Bar of Efficacy for Drug Approval

(2009) Alberto Sobrero et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

(2009) Scott Kopetz et al.   JOURNAL OF CLINICAL ONCOLOGY

Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters

(2009) Walid Fayad et al.   PLoS One

Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization

(2009) K. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The fluorometric microculture cytotoxicity assay

(2008) Elin Lindhagen et al.   Nature Protocols